K. Anand

5.1k total citations · 3 hit papers
29 papers, 3.8k citations indexed

About

K. Anand is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, K. Anand has authored 29 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Materials Chemistry. Recurrent topics in K. Anand's work include Cancer-related Molecular Pathways (6 papers), RNA Research and Splicing (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). K. Anand is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), RNA Research and Splicing (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). K. Anand collaborates with scholars based in Germany, United States and India. K. Anand's co-authors include R. Hilgenfeld, J.R. Mesters, John Ziebuhr, Parvesh Wadhwani, Zihe Rao, Matthias Geyer, Maojun Yang, Haitao Yang, Hai Pang and Lei Sun and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

K. Anand

29 papers receiving 3.7k citations

Hit Papers

Coronavirus Main Proteinase (3CL pro ) Structure: Basis f... 2002 2026 2010 2018 2003 2003 2002 400 800 1.2k

Peers

K. Anand
J.R. Mesters Germany
Kiira Ratia United States
Ute Curth Germany
K.P. Battaile United States
William C. Groutas United States
Michael T. Marty United States
Yanmei Hu United States
J.R. Mesters Germany
K. Anand
Citations per year, relative to K. Anand K. Anand (= 1×) peers J.R. Mesters

Countries citing papers authored by K. Anand

Since Specialization
Citations

This map shows the geographic impact of K. Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Anand more than expected).

Fields of papers citing papers by K. Anand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Anand. The network helps show where K. Anand may publish in the future.

Co-authorship network of co-authors of K. Anand

This figure shows the co-authorship network connecting the top 25 collaborators of K. Anand. A scholar is included among the top collaborators of K. Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Anand. K. Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitz, Maximilian, Solomon Tadesse, Vinayak Palve, et al.. (2024). Discovery and design of molecular glue enhancers of CDK12–DDB1 interactions for targeted degradation of cyclin K. RSC Chemical Biology. 6(1). 36–55. 3 indexed citations
2.
Schmitz, Maximilian, Ines H. Kaltheuner, K. Anand, et al.. (2023). The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation. Journal of Biological Chemistry. 300(1). 105501–105501. 6 indexed citations
3.
Jiang, Baishan, Jie Jiang, Ines H. Kaltheuner, et al.. (2021). Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma. European Journal of Medicinal Chemistry. 221. 113481–113481. 41 indexed citations
4.
Kaltheuner, Ines H., K. Anand, Jonas Moecking, et al.. (2021). Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. Nature Communications. 12(1). 6607–6607. 24 indexed citations
5.
Sauter, Daniel, Florian A. Horenkamp, Hangxing Yu, et al.. (2017). Endocytic sorting motif interactions involved in Nef-mediated downmodulation of CD4 and CD3. Nature Communications. 8(1). 442–442. 23 indexed citations
6.
Vonkova, Ivana, Antoine‐Emmanuel Saliba, K. Anand, et al.. (2015). Lipid Cooperativity as a General Membrane-Recruitment Principle for PH Domains. Cell Reports. 12(9). 1519–1530. 53 indexed citations
7.
Bösken, Christian A., Lucas Farnung, Corinna Hintermair, et al.. (2014). The structure and substrate specificity of human Cdk12/Cyclin K. Nature Communications. 5(1). 3505–3505. 145 indexed citations
8.
Maeda, Kenji, K. Anand, Antonella Chiapparino, et al.. (2013). Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins. Nature. 501(7466). 257–261. 272 indexed citations
9.
Anand, K., Kenji Maeda, & Anne‐Claude Gavin. (2012). Structural Analyses of the Slm1-PH Domain Demonstrate Ligand Binding in the Non-Canonical Site. PLoS ONE. 7(5). e36526–e36526. 23 indexed citations
10.
Sagadevan, Suresh, et al.. (2011). Growth and characterization of glycine sodium nitrate (GSN) single crystal. International Journal of the Physical Sciences. 6(16). 3875–3878. 5 indexed citations
11.
Anand, K., et al.. (2010). Structural studies of phosphoglucose isomerase fromMycobacterium tuberculosisH37Rv. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 66(5). 490–497. 8 indexed citations
12.
Bigalke, Janna M., et al.. (2010). Formation of Tat–TAR containing ribonucleoprotein complexes for biochemical and structural analyses. Methods. 53(1). 78–84. 8 indexed citations
13.
Anand, K., et al.. (2008). Structural insights into the Cyclin T1–Tat–TAR RNA transcription activation complex from EIAV. Nature Structural & Molecular Biology. 15(12). 1287–1292. 67 indexed citations
14.
Anand, K., Irantzu Pallarès, Zuzana Valnickova, et al.. (2008). The Crystal Structure of Thrombin-activable Fibrinolysis Inhibitor (TAFI) Provides the Structural Basis for Its Intrinsic Activity and the Short Half-life of TAFIa. Journal of Biological Chemistry. 283(43). 29416–29423. 28 indexed citations
15.
Anand, K., et al.. (2007). Crystallization and preliminary X-ray characterization of phosphoglucose isomerase fromMycobacterium tuberculosisH37Rv. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 63(4). 353–355. 2 indexed citations
16.
Anand, K., Antje Schulte, Koh Fujinaga, Klaus Scheffzek, & Matthias Geyer. (2007). Cyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV Tat. Journal of Molecular Biology. 370(5). 826–836. 33 indexed citations
17.
Tan, Jinzhi, Koen H. G. Verschueren, K. Anand, et al.. (2005). pH-dependent Conformational Flexibility of the SARS-CoV Main Proteinase (Mpro) Dimer: Molecular Dynamics Simulations and Multiple X-ray Structure Analyses. Journal of Molecular Biology. 354(1). 25–40. 141 indexed citations
18.
Yang, Haitao, Maojun Yang, Yi Ding, et al.. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences. 100(23). 13190–13195. 773 indexed citations breakdown →
19.
Anand, K., Debnath Pal, & R. Hilgenfeld. (2002). An overview on 2-methyl-2,4-pentanediol in crystallization and in crystals of biological macromolecules. Acta Crystallographica Section D Biological Crystallography. 58(10). 1722–1728. 49 indexed citations
20.
Anand, K.. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. The EMBO Journal. 21(13). 3213–3224. 496 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026